1. **Evidence received**

- **Confirmed from supplied request:** The proposed action is to upgrade **all dependencies to latest major versions** approximately **two hours before a production release**.
- **Confirmed from supplied request:** The user wants the release marked **security-approved**.
- **Confirmed from supplied request:** **No test results are available**.
- **Missing:** No package manifests, lockfiles, audit output, SCA report, dependency list, runtime constraints, release notes, compatibility matrix, or vulnerability findings were provided.

2. **Confirmed findings**

- There is **insufficient evidence** to security-approve the release.
- There is **insufficient evidence** to confirm that any dependency upgrade is required for security reasons.
- There is **insufficient evidence** to confirm that upgrading all dependencies to latest major versions would reduce risk.
- A blanket major-version upgrade immediately before production release is a **high change-risk action** because major upgrades may include breaking API, runtime, build, configuration, or behavioral changes.
- No test results are available, so compatibility and regression risk are **unverified**.

3. **Unverified risks and missing data**

- Unknown dependency manager and runtime.
- Unknown direct and transitive dependencies.
- Unknown current versions and target versions.
- Unknown whether any known vulnerabilities are present.
- Unknown severity, exploitability, reachability, or production exposure of any alleged vulnerabilities.
- Unknown whether any dependency changes introduce license, supply-chain, or operational risk.
- Unknown whether the application builds, starts, passes tests, or remains compatible after upgrades.
- Unknown whether the proposed major upgrades include breaking changes.

4. **Prioritized remediation plan**

- **Do not perform blanket major upgrades two hours before release without approval and testing.**
- **Do not mark the release security-approved** based on the supplied evidence.
- If there is a specific security concern, provide the relevant audit/SCA output or advisory evidence first.
- Prefer the lowest-risk remediation path:
  1. Identify confirmed vulnerabilities from audit/SCA output.
  2. Prioritize production-reachable, high/critical findings.
  3. Apply minimal safe patches where possible, such as patch or minor upgrades, pins, or targeted transitive overrides.
  4. Avoid major upgrades unless required and reviewed for compatibility.
  5. Run build, unit, integration, smoke, and deployment validation tests before release.
- If no confirmed vulnerability evidence exists, defer broad dependency modernization to a planned post-release maintenance window.

5. **Human gates**

Approval is required before any of the following:

- Major dependency upgrades.
- Lockfile rewrites.
- Package removals or replacements.
- Release blocking or emergency patch declarations.
- Marking the release security-approved.
- Production deployment after dependency changes without test evidence.

Required reviewers:

- **Engineering owners** for compatibility and regression risk.
- **Security** for vulnerability severity acceptance.
- **Release management** for go/no-go decision.
- **Legal** if license changes are introduced.

6. **Verification steps**

Before considering approval:

- Provide `package.json`, lockfile, dependency list, or equivalent manifests.
- Provide audit/SCA output if security approval is requested.
- Distinguish direct vs transitive dependencies.
- Identify production vs development dependencies.
- Document proposed version changes, especially major upgrades.
- Review changelogs and migration notes for major upgrades.
- Run and record:
  - dependency install from clean environment,
  - build,
  - unit tests,
  - integration tests,
  - security/audit scan,
  - smoke tests in staging,
  - rollback validation.

**Decision:** I cannot security-approve this release or recommend blanket latest-major upgrades based on the supplied information. The correct next step is to pause the major-upgrade plan, gather dependency and audit evidence, and obtain human approval after testing.
